Oklahoma 2024 Regular Session

Oklahoma House Bill HB3934 Latest Draft

Bill / Introduced Version Filed 01/18/2024

                             
 
 
Req. No. 9087 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 59th Legislature (2024) 
 
HOUSE BILL 3934 	By: Provenzano 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to public health; amending 36 O.S. 
2021, Section 6060, as amended by Section 1, Chapter 
294, O.S.L. 2022 (36 O.S. Supp. 2023, Section 6060), 
which relates to coverage for low -dose mammography 
screening; adding a definition; and providing an 
effective date. 
 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF T HE STATE OF OKLAHOMA: 
SECTION 1.    AMENDATORY     36 O.S. 2021, Section 6060, as 
amended by Section 1, Chapter 294, O.S.L. 2022 (36 O.S. Supp. 2023, 
Section 6060), is amended to read as follows : 
Section 36-6060.  A.  For the purposes of this section : 
1.  "Breast magnetic resonance imagi ng" means a diagnostic tool 
used to produce detailed pictures of the structure of the breast; 
2.  "Breast tomosynthesis" means a radiologic mammography 
procedure involving the acquisition of projection images over a 
stationary breast to produce cross-sectional digital three-
dimensional images of the breast from which breast cancer screen ing 
diagnoses may be made;   
 
 
Req. No. 9087 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2. 3.  "Breast ultrasound" means a noninvasive, diagnostic 
imaging technique that uses high-frequency sound waves to pro duce 
detailed images of the breast; 
3. 4.  "Diagnostic examination for breast cancer" means a 
medically necessary and clinically appropriate examination, as 
defined by current guidelines and as determined by a clinician who 
is evaluating the individual for breast cancer, to evaluate the 
abnormality in the breast that is: 
a. seen or suspected from a screening examination for 
breast cancer, 
b. detected by another means of examination, or 
c. suspected based on the medical history o r family 
medical history of the indi vidual. 
This examination may include, but is not limited to, a 
diagnostic mammogram, breast magnetic resonance imaging, or a breast 
ultrasound; 
4. 5.  "Diagnostic mammography" means a diagnostic tool that: 
a. uses X-ray, and 
b. is designed to evaluate abnormality in a breast; 
5. 6.  "Health benefit plan" means any plan or arrangement as 
defined in subsection C of Section 6060.4 of this title; 
6. 7.  "Low-dose mammography" means: 
a. the X-ray examination of the breast using equ ipment 
specifically dedicated for suc h purpose, with an   
 
 
Req. No. 9087 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
average radiation exposure deliver y of less than one 
rad mid-breast and with two views for each breast, 
b. digital mammography, or 
c. breast tomosynthesis; 
7.  "Breast tomosynthesis" means a radiologic mammography 
procedure involving the acquisition of projection images over a 
stationary breast to produce cross-sectional digital three-
dimensional images of the breast from which breast cancer screen ing 
diagnoses may be made; and 
8.  "Screening mammography" means a radiologic procedure 
provided to a woman, who has no signs or symptoms of breast cancer, 
for the purpose of early detection of breast cancer, including 
breast tomosynthesis .; and 
9.  "Supplemental breast examinations" means a medically 
necessary and clinically appropriate examination of the b reast, 
including but not limited to, as examination using contrast -enhanced 
mammography, diagnostic mammography, breast magnetic resonance 
imaging, or breast ultrasound that is: 
a. used to screen for breast cancer when there is no 
abnormality seen or suspe cted, and 
b. based on personal or family medical history, or 
additional factors that may increase the individual 's 
risk of breast cancer.   
 
 
Req. No. 9087 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  All health benefit plans shall include the coverage 
specified by this section for a low -dose mammography screening for 
the presence of occult breast cancer and a diagnostic examination 
for breast cancer.  Such coverage shall not: 
1.  Be subject to the policy deductib le, co-payments and co-
insurance limits of the plan; or 
2.  Require that a female undergo a mammography screening at a 
specified time as a conditi on of payment. 
C.  1.  Any female thirty-five (35) through thirty-nine (39) 
years of age shall be entitled pur suant to the provisions of this 
section to coverage for a low-dose mammography screening once every 
five (5) years. 
2.  Any female forty (40) ye ars of age or older shall be 
entitled pursuant to the provisions of this section to coverage for 
an annual low-dose mammography screening. 
D.  If application of this act would result in health savings 
account ineligibility under Section 223 of the federal Internal 
Revenue Code, as amended, the pro visions of this section shall only 
apply to health savings accounts wi th qualified high-deductible 
health plans with respect to the deductible of such a plan after the 
enrollee has satisfied the minimum deductible.  Provided, however, 
the provisions of thi s section shall apply to items of services that 
are preventive care pursuant to Section 223(c)(2)(c) of the federal   
 
 
Req. No. 9087 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Internal Revenue Cod e, as amended, regardless of w hether the minimum 
deductible has been satisfied. 
SECTION 2.  This act shall become effective November 1, 2024. 
 
59-2-9087 TJ 12/07/23